All JP will say is that he would put shareholders first, stop dilution, be a stand-up ceo, strike down the walled garden, and strike a deal with BP worth $35-50m upfront payments + 10-15% stake in LymPro + milestone payments & royalties...
which, is the precise reason JP is a armchair CEO.
it's easier SAID than DONE.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links